Geode Capital Management, LLC Bolt Biotherapeutics, Inc. Transaction History

Geode Capital Management, LLC

  • $1.24 Trillion
  • Q1 2025

A detailed history of Geode Capital Management, LLC transactions in Bolt Biotherapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 375,113 shares of BOLT stock, worth $112,533. This represents 0.0% of its overall portfolio holdings.

Number of Shares
375,113
Previous 340,674 10.11%
Holding current value
$112,533
Previous $187,000 19.79%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025
BUY
$0.4 - $0.62 $13,775 - $21,352
34,439 Added 10.11%
375,113 $150,000
Q4 2024

Feb 12, 2025
SELL
$0.5 - $0.68 $5,876 - $7,991
-11,752 Reduced 3.33%
340,674 $187,000
Q3 2024

Nov 12, 2024
SELL
$0.58 - $0.75 $10,651 - $13,773
-18,364 Reduced 4.95%
352,426 $229,000
Q2 2024

Aug 09, 2024
BUY
$0.73 - $1.5 $16,952 - $34,834
23,223 Added 6.68%
370,790 $278,000
Q1 2024

May 13, 2024
SELL
$1.01 - $1.4 $2,622 - $3,635
-2,597 Reduced 0.74%
347,567 $486,000
Q4 2023

Feb 13, 2024
SELL
$0.85 - $1.12 $8,988 - $11,844
-10,575 Reduced 2.93%
350,164 $392,000
Q3 2023

Nov 13, 2023
BUY
$0.98 - $1.46 $8,349 - $12,439
8,520 Added 2.42%
360,739 $375,000
Q2 2023

Aug 11, 2023
BUY
$1.27 - $1.95 $221,268 - $339,742
174,227 Added 97.88%
352,219 $450,000
Q1 2023

May 15, 2023
BUY
$1.29 - $1.66 $30,851 - $39,700
23,916 Added 15.52%
177,992 $247,000
Q4 2022

Feb 13, 2023
BUY
$1.26 - $1.51 $14,934 - $17,898
11,853 Added 8.33%
154,076 $200,000
Q2 2022

Aug 12, 2022
SELL
$1.41 - $2.91 $260,105 - $536,813
-184,472 Reduced 56.47%
142,223 $290,000
Q1 2022

May 13, 2022
SELL
$2.74 - $4.82 $179,297 - $315,406
-65,437 Reduced 16.69%
326,695 $895,000
Q4 2021

Feb 11, 2022
BUY
$4.19 - $13.97 $197,001 - $656,827
47,017 Added 13.62%
392,132 $1.92 Million
Q3 2021

Nov 12, 2021
BUY
$11.15 - $18.6 $1.5 Million - $2.51 Million
134,962 Added 64.22%
345,115 $4.37 Million
Q2 2021

Aug 13, 2021
BUY
$15.4 - $31.46 $4,404 - $8,997
286 Added 0.14%
210,153 $3.25 Million
Q1 2021

May 12, 2021
BUY
$25.86 - $39.93 $5.43 Million - $8.38 Million
209,867 New
209,867 $6.91 Million

Others Institutions Holding BOLT

# of Institutions
29
Shares Held
18.1M
Call Options Held
0
Put Options Held
0
View Full List

About Bolt Biotherapeutics, Inc.

BOLT Quotes by TradingView
  • Ticker BOLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,641,500
  • Market Cap $11.3M
  • Description
  • Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-e...
More about BOLT
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email